---
schema_version: "secwatch.filing_event.v1"
accession: "0001034842-26-000041"
form_type: "8-K"
ticker: "RIGL"
cik: "0001034842"
company_name: "RIGEL PHARMACEUTICALS INC"
filed_at: "2026-05-20T20:10:19+00:00"
generated_at: "2026-05-20T21:37:24.860341+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Rigel shareholders approve equity plan amendments adding 860K shares; re-elect directors

## Summary
- Stockholders approved amendment to 2018 Equity Incentive Plan, adding 500,000 shares.
- Stockholders approved amendment to 2000 ESPP, adding 360,000 shares.
- Directors Alison Hannah, Walter Moos, Raul Rodriguez re-elected with >86% votes cast in favor.
- Advisory say-on-pay approved with 9,013,480 votes for (87.5% of votes cast).
- Ratification of Ernst & Young as FY2026 auditor passed with 12,590,773 votes for.

## SEC filing metadata
- accession: 0001034842-26-000041
- form_type: 8-K
- ticker: RIGL
- cik: 0001034842
- company_name: RIGEL PHARMACEUTICALS INC
- filed_at: 2026-05-20T20:10:19+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02, 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1034842/000103484226000041/0001034842-26-000041-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1034842/000103484226000041/rigl-20260514.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001034842-26-000041
- JSON: https://secwatch.observer/filing/0001034842-26-000041.json
- Plain text: https://secwatch.observer/filing/0001034842-26-000041.txt

## Key facts
- Shareholder Votes
  RIGEL PHARMACEUTICALS INC shareholders approved Ratification of Selection of Ernst & Young at the 2026-12-31 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2026-12-31
  source text: Ratification of Selection of Ernst & Young The Company’s stockholders ratified the selection of Ernst & Young LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026. For Against Abstain Broker Non-Votes 12,590,773 1,506,852 29,809 —
  evidence_url: https://www.sec.gov/Archives/edgar/data/1034842/000103484226000041/0001034842-26-000041-index.htm
- Shareholder Votes
  RIGEL PHARMACEUTICALS INC shareholders approved Say-on-Pay.
  - Proposal: say on pay
  - Outcome: passed
  source text: Say-on-Pay The Company’s stockholders approved, on an advisory basis, the compensation of the Company’s named executive officers as disclosed in the Proxy Statement. For Against Abstain Broker Non-Votes 9,013,480 1,291,609 416,316 3,406,029
  evidence_url: https://www.sec.gov/Archives/edgar/data/1034842/000103484226000041/0001034842-26-000041-index.htm
- Shareholder Votes
  RIGEL PHARMACEUTICALS INC shareholders approved Election of Directors.
  - Proposal: director election
  - Outcome: passed
  source text: Election of Directors Each of the nominees for director, to serve until the Company’s 2029 Annual Meeting of Stockholders or until his or her respective successor has been elected and qualified, was elected as follows: Name of Director For Withheld Abstain Broker Non-Votes Alison Hannah, M.D. 9,202,113 1,469,709 49,583 3,406,029 Walter Moos, Ph.D. 10,436,673 242,736 41,996 3,406,029 Raul Rodriguez 10,486,503 192,614 42,288 3,406,029
  evidence_url: https://www.sec.gov/Archives/edgar/data/1034842/000103484226000041/0001034842-26-000041-index.htm
- Shareholder Votes
  RIGEL PHARMACEUTICALS INC shareholders approved Approval of the Amended 2018 Equity Incentive Plan.
  - Proposal: equity plan
  - Outcome: passed
  source text: Approval of the Amended 2018 Equity Incentive Plan The Company’s stockholders approved the Amended 2018 Equity Incentive Plan. For Against Abstain Broker Non-Votes 6,497,964 3,813,701 409,740 3,406,029
  evidence_url: https://www.sec.gov/Archives/edgar/data/1034842/000103484226000041/0001034842-26-000041-index.htm
- Shareholder Votes
  RIGEL PHARMACEUTICALS INC shareholders approved Approval of the 2000 Employee Stock Purchase Plan.
  - Proposal: equity plan
  - Outcome: passed
  source text: Approval of the 2000 Employee Stock Purchase Plan The Company’s stockholders approved the Amended 2000 Employee Stock Purchase Plan. For Against Abstain Broker Non-Votes 9,840,922 475,464 405,019 3,406,029
  evidence_url: https://www.sec.gov/Archives/edgar/data/1034842/000103484226000041/0001034842-26-000041-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.